TY  - GEN
AU  - Hirokawa,Yumiko
AU  - Levitzki,Alexander
AU  - Lessene,Guillaume
AU  - Baell,Jonathan
AU  - Xiao,Yi
AU  - Zhu,Hongjian
AU  - Maruta,Hiroshi
TI  - Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors)
SN  - 0304-3835
PY  - 2007///0405
KW  - Animals
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - drug effects
KW  - Depsipeptides
KW  - Dose-Response Relationship, Drug
KW  - Drug Synergism
KW  - Enzyme Inhibitors
KW  - Humans
KW  - Mammary Neoplasms, Experimental
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Mice, Nude
KW  - Molecular Structure
KW  - Neurofibromin 1
KW  - deficiency
KW  - Nitriles
KW  - Pancreatic Neoplasms
KW  - Protein-Tyrosine Kinases
KW  - antagonists & inhibitors
KW  - Pyrazoles
KW  - Pyrimidines
KW  - Quaternary Ammonium Compounds
KW  - Signal Transduction
KW  - Time Factors
KW  - Treatment Outcome
KW  - Xenograft Model Antitumor Assays
KW  - methods
KW  - src-Family Kinases
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.canlet.2006.01.018
ER  -